Correspondence 0001104659-23-042884 from Nutex Health Inc. (NUTX)
Nutex Health Inc.
Date: April 7, 2023 · CIK: 0001479681 · Accession: 0001104659-23-042884
AI Filing Summary & Sentiment
File numbers found in text: 333-270886
Letter
Re: Nutex Health Inc.
VIA EDGAR
April 7, 2023
United States Securities and Exchange Commission
Division of Corporation Finance
100 F Street, N.E.
Washington, D.C. 20549-3561
Registration Statement on Form S-3
File No. 333-270886
Ladies and Gentlemen:
On behalf of Nutex Health Inc., and pursuant to Rule 461 promulgated under the Securities Act of 1933, as amended, the undersigned hereby requests that the effective date of the above referenced Registration Statement on Form S-3 be accelerated to 10:00 a.m., Washington, D.C. time, on Friday, April 7, 2023, or as soon as practicable thereafter.
Thank you for your assistance in this matter. If you need any additional information, please contact Gislar Donnenberg of Locke Lord LLP at (713) 226-1351.
Very truly yours,
Nutex Health Inc.
Show Raw Text
CORRESP
1
filename1.htm
VIA EDGAR
April 7, 2023
United States Securities and Exchange Commission
Division of Corporation Finance
100 F Street, N.E.
Washington, D.C. 20549-3561
Re:
Nutex Health Inc.
Registration Statement on Form S-3
File No. 333-270886
Ladies and Gentlemen:
On behalf of Nutex Health
Inc., and pursuant to Rule 461 promulgated under the Securities Act of 1933, as amended, the undersigned hereby requests that the effective
date of the above referenced Registration Statement on Form S-3 be accelerated to 10:00 a.m., Washington, D.C. time, on Friday, April
7, 2023, or as soon as practicable thereafter.
Thank you for your assistance
in this matter. If you need any additional information, please contact Gislar Donnenberg of Locke Lord LLP at (713) 226-1351.
Very truly yours,
Nutex Health Inc.
By:
/s/ Jon C. Bates
Name:
Jon C. Bates
Title:
Chief Financial Officer